Quantcast

Latest renal dialysis Stories

2014-08-20 23:02:26

A common approach to treating kidney failure by removing waste products from the blood did not improve survival chances for people who suddenly developed the condition, in a new analysis led by experts at the University of Pittsburgh School of Medicine. Pittsburgh, PA (PRWEB) August 20, 2014 A common approach to treating kidney failure by removing waste products from the blood did not improve survival chances for people who suddenly developed the condition, in an analysis led by experts...

2014-08-18 23:05:40

Mathea Ford, Registered Dietitian, Author and CEO of Renal Diet Headquarters will be presenting “Dining Out While on Dialysis…Yes You Can” at the National Patient Meeting for the American Association of Kidney Patients at the Flamingo Hotel in Las Vegas, NV on September 26-28, 2014. Renal Diet Headquarters provides nutrition, meal planning and renal diet counseling and services to kidney patients in various stages of the disease. Moore, OK (PRWEB) August 18, 2014 During the...

2014-08-14 20:22:56

RIVER EDGE, N.J., Aug. 14, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three and six months ended June 30, 2014. Recent Highlights -- First commercial use of the Nephros on-line mid-dilution hemodiafiltration...

2014-08-14 16:27:40

Signs Business Collaboration in South Korea with Wonik Corporation BRIDGEWATER, N.J., Aug. 14, 2014 /PRNewswire/ -- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious disease, today announced the U.S. Food and Drug Administration (FDA) has agreed with the design of our pivotal Phase III protocol for Neutrolin® in Hemodialysis patients, and the company...

2014-08-13 12:28:08

If Implemented, Program Risks Confusing, Misleading Patients and Public WASHINGTON, Aug. 13, 2014 /PRNewswire-USNewswire/ -- Kidney Care Partners (KCP), concerned that the Centers for Medicare and Medicaid Services' (CMS) planned End-Stage Renal Disease (ESRD) Five-Star Program will confuse and mislead patients, called on the Agency to delay implementation and work with the community to provide useful, meaningful, and accurate ratings of dialysis providers. KCP is a broad-based coalition of...

2014-08-12 08:30:15

LAWRENCE, Mass., Aug. 12, 2014 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today that Allan J. Collins, M.D., a recognized worldwide leader in the field of nephrology, will join the Company as Senior Medical Advisor and head the Company's Medical Advisory Board. http://photos.prnewswire.com/prnvar/20110503/MM94799LOGO Dr. Collins is a Professor of Medicine at the University of Minnesota. He is the...

2014-08-12 04:21:14

Four internationally renowned renal care specialists to assist Quanta as it prepares for the clinical introduction of its advanced haemodialysis system ALCESTER, England, August 12, 2014 /PRNewswire/ -- Quanta Fluid Solutions Ltd ("Quanta" or the "Company"), a pioneering developer of advanced haemodialysis systems, today announces it has appointed four leading renal experts to its newly established Medical Advisory Board. Prof. John Agar, Dr. Roger Greenwood, Dr. Clara Day and...

2014-08-07 04:21:45

ALCESTER, England, August 7, 2014 /PRNewswire/ -- Quanta Fluid Solutions Ltd ("Quanta" or the "Company"), a pioneering developer of advanced haemodialysis systems, today announces the appointment of Willem Baralt as Chief Financial Officer. Willem has almost twenty years of investment banking, executive management and private equity experience. Amongst his achievements, Willem was pivotal in the $1.6billion turnaround and public listing of FLAG Telecom and was...

2014-08-06 12:29:28

Nephrologists Seem More Confident That an Iron-Based Phosphate Binder Will Impact the Use of IV Iron vs. the Use of ESAs, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 6, 2014 /PRNewswire/ -- Decision Resources Group finds that there is a high need for new phosphate binders to treat hyperphosphatemia among surveyed U.S. nephrologists (n=102). Phosphate binders with fewer pills, better efficacy in reducing serum phosphorous and improved tolerability are rated as...

2014-07-30 08:32:14

SAN ANTONIO, July 30, 2014 /PRNewswire/ -- Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced it has closed $4.5 million in Series A financing, which was led by Targeted Technology Fund II. Proceeds from the deal will allow Bluegrass Vascular to obtain CE Mark for the Surfacer(TM) Inside-Out Access Catheter System, enhance manufacturing capabilities, and proceed with US...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.